[go: up one dir, main page]

TR200102024T2 - Yeni tedavi. - Google Patents

Yeni tedavi.

Info

Publication number
TR200102024T2
TR200102024T2 TR2001/02024T TR200102024T TR200102024T2 TR 200102024 T2 TR200102024 T2 TR 200102024T2 TR 2001/02024 T TR2001/02024 T TR 2001/02024T TR 200102024 T TR200102024 T TR 200102024T TR 200102024 T2 TR200102024 T2 TR 200102024T2
Authority
TR
Turkey
Prior art keywords
hepatitis
virus
new treatment
antiviral agent
infection
Prior art date
Application number
TR2001/02024T
Other languages
English (en)
Inventor
Frances Atkinson Gillian
James Boon Ronald
G. Vandepapeliere Pierre
Anne Cecile Wettendorff Martine
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of TR200102024T2 publication Critical patent/TR200102024T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu bulus hepatit B enfeksiyonunun önlenmesi ve/ya da tedavi edilmesi için, aktif maddeler olarak (1) hepatit B virüsüne karsi aktif olan antiviral bir ajani ve (2) bir asiyi içeren farmasötik bir paket saglar, aktif maddeler es zamanli ya da sirasiyla kullanilmaktadirlar. Tercih edilen maddeler bir hepatit B virüsü yüzey antijenini içeren bir hepatit B virüsü asisiyla birlikte antiviral ajan olarak bir nükleosit benzeridir.
TR2001/02024T 1999-01-12 1999-12-21 Yeni tedavi. TR200102024T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9900630 1999-01-12

Publications (1)

Publication Number Publication Date
TR200102024T2 true TR200102024T2 (tr) 2001-12-21

Family

ID=10845878

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02024T TR200102024T2 (tr) 1999-01-12 1999-12-21 Yeni tedavi.

Country Status (19)

Country Link
EP (1) EP1140163A2 (tr)
JP (1) JP2002534438A (tr)
KR (1) KR20010090011A (tr)
CN (1) CN1391482A (tr)
AR (1) AR022250A1 (tr)
AU (1) AU760574B2 (tr)
BR (1) BR9916893A (tr)
CA (1) CA2359110A1 (tr)
CO (1) CO5241355A1 (tr)
CZ (1) CZ20012544A3 (tr)
HK (1) HK1041434A1 (tr)
HU (1) HUP0105070A2 (tr)
IL (1) IL144186A0 (tr)
NO (1) NO20013337L (tr)
NZ (1) NZ512890A (tr)
PL (1) PL349347A1 (tr)
TR (1) TR200102024T2 (tr)
WO (1) WO2000041463A2 (tr)
ZA (1) ZA200105690B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69932717T2 (de) 1998-05-22 2007-08-09 Ottawa Health Research Institute, Ottawa Methoden und produkte zur induzierung mukosaler immunität
CN102198266A (zh) 1998-07-31 2011-09-28 株式会社国际癌症免疫研究所 基于癌抑制基因wt1的产物的癌抗原
BRPI0208183B8 (pt) 2001-03-22 2021-05-25 Sugiyama Haruo peptídeo antígeno de câncer modificado por wt1 e vacinas para câncer
WO2003028758A1 (en) * 2001-09-28 2003-04-10 Haruo Sugiyama Novel method of inducing antigen-specific t cells
WO2003028757A1 (en) * 2001-09-28 2003-04-10 Haruo Sugiyama Novel method of inducing antigen-specific t cells
TWI275392B (en) * 2002-04-08 2007-03-11 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
BR0315810A (pt) 2002-10-29 2005-09-13 Coley Pharmaceutical Group Ltd Uso de oligonucleotìdeos cpg no tratamento de infecção por vìrus da hepatite c
EP1578954A4 (en) 2002-12-11 2010-08-11 Coley Pharm Group Inc 5'-CPG NUCLEIC ACIDS AND USE METHOD
CN100443117C (zh) * 2003-05-13 2008-12-17 深圳康泰生物制品股份有限公司 一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途
US8541167B2 (en) 2004-06-03 2013-09-24 Saint Louis University Methods and compositions for vaccination
AR065504A1 (es) * 2007-02-28 2009-06-10 Ct Ingenieria Genetica Biotech Terapia combinada para el tratamiento de la hepatitis b cronica. uso.
EP3903815A4 (en) 2018-12-24 2022-09-28 Grand Theravac Life Science (Nanjing) Co., Ltd. PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HEPATITIS B, METHOD OF MANUFACTURE THEREOF AND USE THEREOF
EP4321173A4 (en) * 2021-04-07 2025-08-20 Denka Company Ltd ADJUVANT ACTIVITY ACTIVATOR AND ADJUVANT COMPOSITION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG48175A1 (en) * 1989-07-25 1998-04-17 Smithkline Beecham Biolog Novel antigens and method for their preparation
PL343429A1 (en) * 1998-03-09 2001-08-13 Smithkline Beecham Biolog Combined vaccine compositions

Also Published As

Publication number Publication date
KR20010090011A (ko) 2001-10-17
CO5241355A1 (es) 2003-01-31
BR9916893A (pt) 2001-11-20
NO20013337D0 (no) 2001-07-05
WO2000041463A2 (en) 2000-07-20
ZA200105690B (en) 2002-09-25
WO2000041463A3 (en) 2000-11-09
AU760574B2 (en) 2003-05-15
HK1041434A1 (zh) 2002-07-12
JP2002534438A (ja) 2002-10-15
CA2359110A1 (en) 2000-07-20
IL144186A0 (en) 2002-05-23
NZ512890A (en) 2003-09-26
NO20013337L (no) 2001-08-17
EP1140163A2 (en) 2001-10-10
PL349347A1 (en) 2002-07-15
CN1391482A (zh) 2003-01-15
CZ20012544A3 (cs) 2002-01-16
AR022250A1 (es) 2002-09-04
AU2100900A (en) 2000-08-01
HUP0105070A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
HUP0002224A1 (hu) Virusellenes hatású benzimidazol-származékok
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
EE05065B1 (et) Karbamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
NO20025627D0 (no) Fremgangsmåter og sammensetninger for å behandle hepatitt C virus
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
BR0011433B1 (pt) Compostos de imidazoquinolinas substituídas com sulfonamida e sulfamida e composição farmaceutica cotendo os mesmos
TR200102024T2 (tr) Yeni tedavi.
NO20034204D0 (no) Farmasöytiske kombinasjoner til behandling av kreft
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
DE69838986D1 (de) Polypeptide, deren herstellung und verwendung
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
ATE185483T1 (de) Antivirale nucleosidkombination
ATE231839T1 (de) Polyaromatische antivirale zusammensetzungen
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
ATE310089T1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
BR9808100A (pt) Utilização de amandantina para tratamento de hepatite c.
EE200200087A (et) Kompositsioon hepatotsellulaarse kartsinoomi raviks
DE69909747D1 (de) Pharmazeutische zusammensetzung, enthaltend peg-asparaginase, für die behandlung von hiv infektionen
BR0317539A (pt) Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais
DK1140113T3 (da) Anvendelse af bisphosphonater til profylakse og behandling af infektiøse processer
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
ATE58478T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
ATE342734T1 (de) Adenosin a1 antagonisten gegen männliche sterilität
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen